SynBioBeta SF 2016 Related News

Sangamo BioSciences Changes Name To Sangamo Therapeutics, Underscoring Focus On Clinical Development Of Genomic Therapies

RICHMOND, Calif., Jan. 6, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announces that it has changed its corporate name, from "Sangamo BioSciences, Inc." to "Sangamo Therapeutics, Inc." Sangamo common stock will continue to trade [...]

By | January 10th, 2017|BioPharma & Healthcare, News, SynBioBeta SF 2016, Therapeutics|

Keeping Biosecurity in the Forefront: A Conversation with Renee Wegrzyn

This year’s annual SynBioBeta SF 2016 conference featured a lively panel discussion on how stakeholders in the synthetic biology industry can go about safeguarding the bioeconomy. Panelists from the FBI, DARPA, academia, and industry all weighed in on this topic [...]

By | December 28th, 2016|News, SynBioBeta SF 2016|

Global Bioenergies plans to acquire Dutch start-up Syngip B.V.

Evry (France) and Vaals (Netherlands), 21 December 2016 – Global Bioenergies (Alternext Paris: ALGBE) today signed a contribution agreement with the shareholders of Syngip B.V. to transfer all Syngip shares to Global Bioenergies S.A. The transaction’s completion remains subject to the fulfilment [...]

Takeaways from SynBioBeta SF 2016 for Entrepreneurs and Investors

In the opening keynote for SynBioBeta SF 2016, Dr. Chris Voigt of MIT demonstrated just how far the field of synthetic biology has come. The Cello program that was developed in his lab is able to rationally design complex biological [...]

By | October 18th, 2016|News, SynBioBeta SF 2016|

Recapping SynBioBeta SF 2016

As many of our readers know, last week SynBioBeta held its fifth annual San Francisco conference, and—as many of those who attended know—it was the largest and most successful yet.  Attendees representing dozens of companies and firms came out to [...]

By | October 18th, 2016|News, SynBioBeta SF 2016|

Last Week in Biotech: 10 Highlights from SynBioBeta SF 2016

It’s been a thrilling few weeks in the world of synthetic biology and biotechnology in San Francisco. In addition to SynBioBeta SF 2016, we’ve seen a number of exciting announcements across different markets. Here’s a quick recap of 10 key [...]

By | October 18th, 2016|News, SynBioBeta SF 2016|